Our Solutions

Test Your Knowledge —Investigational New Drugs

If you work in, or around, the early phase drug development landscape, you are likely aware of the requirements for an investigational new drug (IND) package. We provided the key considerations in our November 2019 Altascientist, which you can refer to for answers in this quick (less than five minutes), fun test of your knowledge!

Start the quiz



Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.

Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.

Learn More

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.